Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 10Pain, Postoperative 9Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 8Lung Neoplasms 8Stomach Neoplasms 6Colonic Neoplasms 6Brain Neoplasms 6Thyroid Neoplasms 5Prostatic Neoplasms 5Colorectal Neoplasms 5Agnosia 4Thromboembolism 3Pain 3Ovarian Neoplasms 3Myofibroma 3Head and Neck Neoplasms 3Depression 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Uterine Neoplasms 2Urinary Bladder Neoplasms 2Supratentorial Neoplasms 2Neoplasm Metastasis 2Leiomyoma 2Hemangioma 2Arthritis, Rheumatoid 2Vomiting 1Visceral Pain 1Uterine Cervical Neoplasms 1

Interventions

Cyclophosphamide 216Methotrexate 140Cytarabine 131Vincristine 110fludarabine phosphate 103Peripheral Blood Stem Cell Transplantation 98Filgrastim 92Etoposide 92Dexamethasone 89Mycophenolic Acid 71Doxorubicin 70Whole-Body Irradiation 67Mercaptopurine 66Busulfan 65Tacrolimus 64Radiotherapy 63Cyclosporine 62Prednisone 55Daunorubicin 53pegaspargase 51Asparaginase 51Rituximab 48fludarabine 47Granulocyte Colony-Stimulating Factor 46Melphalan 45Antilymphocyte Serum 43Clofarabine 42Calcium Dobesilate 38Methylprednisolone 36Leucovorin 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Saline Solution × Clear all
NCT03593304 2020-07-08

Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia Patients

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Phase 2/3 Completed
40 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡